Lombard Odier Asset Management (USA)’s Pacific Biosciences PACB Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-31,819	Closed	-$58.2K	–	295
2024 Q4	$58.2K	Buy	+31,819	New	+$62.1K	﹤0.01%	284
2024 Q3	–	Sell	-94,557	Closed	-$130K	–	331
2024 Q2	$130K	Buy	94,557 +20,092	+27%	+$40.6K	0.01%	244
2024 Q1	$279K	Buy	+74,465	New	+$436K	0.01%	302
2020 Q3	–	Sell	-407,273	Closed	-$1.41M	–	284
2020 Q2	$1.41M	Hold	407,273	–	–	0.1%	162
2020 Q1	$1.25M	Sell	407,273 -45,253	-10%	-$185K	0.13%	140
2019 Q4	$2.33M	Buy	452,526 +152,526	+51%	+$775K	0.21%	118
2019 Q3	$1.55M	Buy	+300,000	New	+$1.68M	0.15%	156
2019 Q2	–	Sell	-80,000	Closed	-$578K	–	279
2019 Q1	$578K	Sell	80,000 -40,000	-33%	-$289K	0.05%	199
2018 Q4	$888K	Sell	120,000 -680,000	-85%	-$4.31M	0.07%	179
2018 Q3	$4.33M	Buy	+800,000	New	+$3.43M	0.32%	102
2016 Q4	–	Sell	-200,000	Closed	-$1.79M	–	229
2016 Q3	$1.79M	Buy	+200,000	New	+$1.67M	0.17%	159

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return

EDRH

Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s PACB Position: Q1 2025 in Review

Lombard Odier Asset Management (USA) sold out of Pacific Biosciences (PACB) in Q1 2025, closing a stake of 31,819 shares — an estimated $58.2K sold.

Lombard Odier Asset Management (USA) first reported a position in PACB in Q3 2016 and held it in 11 quarters. The position peaked at $4.33M in Q3 2018. 225 funds tracked by Wall St. Rank hold PACB as of Q1 2025.

Lombard Odier Asset Management (USA) reported no remaining Pacific Biosciences position as of Q1 2025 after selling out during the quarter.
Lombard Odier Asset Management (USA) sold 31,819 Pacific Biosciences shares in Q1 2025, an estimated $58.2K.
Lombard Odier Asset Management (USA) first reported a position in Pacific Biosciences in Q3 2016 and held it in 11 quarters.
Lombard Odier Asset Management (USA)'s Pacific Biosciences position peaked at $4.33M in Q3 2018.
225 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2025.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q1 2025, filed 15 May 2025.